$45.91
0.731.62%
Last update: 1:02 PM
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
05/02/2024 | RARE | Ultragenyx Pharmaceutical | FY | 2024 | — | — | — | $500.00M | $530.00M | $513.00M | Get Alert |
02/15/2024 | RARE | Ultragenyx Pharmaceutical | FY | 2024 | — | — | — | $500.00M | $530.00M | $504.31M | Get Alert |
01/08/2024 | RARE | Ultragenyx Pharmaceutical | FY | 2023 | — | — | — | $430.00M | $435.00M | $436.11M | Get Alert |
01/08/2024 | RARE | Ultragenyx Pharmaceutical | FY | 2024 | — | — | — | $500.00M | $530.00M | $523.86M | Get Alert |
11/02/2023 | RARE | Ultragenyx Pharmaceutical | FY | 2023 | — | — | — | $425.00M | $450.00M | $438.74M | Get Alert |
10/16/2023 | RARE | Ultragenyx Pharmaceutical | Q3 | 2023 | — | — | — | $96.00M | $100.00M | $113.33M | Get Alert |
08/03/2023 | RARE | Ultragenyx Pharmaceutical | FY | 2023 | — | — | — | $425.00M | $450.00M | $437.55M | Get Alert |
05/04/2023 | RARE | Ultragenyx Pharmaceutical | FY | 2023 | — | — | — | $425.00M | $450.00M | $435.57M | Get Alert |
02/16/2023 | RARE | Ultragenyx Pharmaceutical | FY | 2023 | — | — | — | $425.00M | $450.00M | $432.78M | Get Alert |
01/13/2020 | RARE | Ultragenyx Pharmaceutical | FY | 2019 | — | — | — | $102.00M | $104.00M | $100.68M | Get Alert |
There have been no specific sales or earnings guidance reported for Ultragenyx Pharmaceutical in recent months.
Browse guidance and forecast on all stocks.